Scrip Asia 100 Ranking: 2024 Pharmaceutical Sales

Explore Scrip’s annual deep dive into the top 100 Asia-Pacific biopharma companies for 2026, featuring key trends, market shifts, and innovation-driving deals shaping the region’s pharmaceutical landscape.